Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcription Factor Protein Interactomes Reveal Genetic Determinants in Heart Disease

ABSTRACT: Transcription Factor Protein Interactomes Reveal Genetic Determinants in Heart Disease

PROVIDER: PRJNA668812 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12815900.fastq.gz	Fastqsanger.gz
	SRR12815901.fastq.gz	Fastqsanger.gz
	SRR12815902.fastq.gz	Fastqsanger.gz
	SRR12815903.fastq.gz	Fastqsanger.gz
	SRR12815904.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 129

Similar Datasets

Transcription Factor Protein Interactomes Reveal Genetic Determinants in Heart Disease

Project description:Congenital Heart Disease (CHD) is present in 1% of live births, and while large-scale genetic studies have uncovered genes associated with CHDs, identifying causal mutations remains a challenge. We hypothesized that genetic determinants for CHDs could be found in the protein interactomes of GATA4 and TBX5, two cardiac transcription factors (TFs) that cause CHDs. Defining their interactomes in human cardiac progenitors via affinity purification-mass spectrometry and integrating the results with genetic data from the Pediatric Cardiac Genomic Consortium (PCGC) revealed an enrichment of de novo variants among proteins that interact with GATA4 or TBX5. A consolidative score designed to prioritize TF interactome members based on distinctive variant, gene, and proband features identified numerous likely CHD-causing genes, including the epigenetic reader GLYR1. GLYR1 and GATA4 widely co-occupied cardiac developmental genes, resulting in co-activation, and the GLYR1 variant associated with CHD disrupted interaction with GATA4. This integrative proteomic and genetic approach provides a framework for prioritizing and interrogating the contribution of genetic variants in CHD and can be extended to other genetic diseases.

2022-02-18 | GSE159411 | GEO

Transcription factor protein interactomes reveal genetic determinants in heart disease.

Project description:Congenital heart disease (CHD) is present in 1% of live births, yet identification of causal mutations remains challenging. We hypothesized that genetic determinants for CHDs may lie in the protein interactomes of transcription factors whose mutations cause CHDs. Defining the interactomes of two transcription factors haplo-insufficient in CHD, GATA4 and TBX5, within human cardiac progenitors, and integrating the results with nearly 9,000 exomes from proband-parent trios revealed an enrichment of de novo missense variants associated with CHD within the interactomes. Scoring variants of interactome members based on residue, gene, and proband features identified likely CHD-causing genes, including the epigenetic reader GLYR1. GLYR1 and GATA4 widely co-occupied and co-activated cardiac developmental genes, and the identified GLYR1 missense variant disrupted interaction with GATA4, impairing in vitro and in vivo function in mice. This integrative proteomic and genetic approach provides a framework for prioritizing and interrogating genetic variants in heart disease.

| S-EPMC8923057 | biostudies-literature

Nociceptor-immune interactomes reveal insult-specific immune signatures of pain

Project description:Nociceptor-immune interactomes reveal insult-specific immune signatures of pain

| PRJNA1076164 | ENA

An Unbiased Lipid Phenotyping Approach To Study the Genetic Determinants of Lipids and Their Association with Coronary Heart Disease Risk Factors

Project description:Direct infusion high-resolution mass spectrometry (DIHRMS) is a novel, high-throughput approach to rapidly and accurately profile hundreds of lipids in human serum without prior chromatography, facilitating in-depth lipid phenotyping for large epidemiological studies to reveal the detailed associations of individual lipids with coronary heart disease (CHD) risk factors. Intact lipid profiling by DIHRMS was performed on 5662 serum samples from healthy participants in the Pakistan Risk of Myocardial Infarction Study (PROMIS). We developed a novel semi-targeted peak-picking algorithm to detect mass-to-charge ratios in positive and negative ionization modes. We analyzed lipid partial correlations, assessed the association of lipid principal components with established CHD risk factors and genetic variants, and examined differences between lipids for a common genetic polymorphism. The DIHRMS method provided information on 360 lipids (including fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, and sterol lipids), with a median coefficient of variation of 11.6% (range: 5.4-51.9). The lipids were highly correlated and exhibited a range of associations with clinical chemistry biomarkers and lifestyle factors. This platform can provide many novel insights into the effects of physiology and lifestyle on lipid metabolism, genetic determinants of lipids, and the relationship between individual lipids and CHD risk factors.

2024-02-02 | MTBLS4461 | MetaboLights

Dengue and Zika RNA-RNA interactomes reveal virus permissive and restrictive factors in human cells.

Project description:Dengue and Zika RNA-RNA interactomes reveal virus permissive and restrictive factors in human cells.

| PRJNA736235 | ENA

RNA-RNA interactomes of Hfq and ProQ reveal overlapping and competing roles for RNA chaperones

Project description:RNA-RNA interactomes of Hfq and ProQ reveal overlapping and competing roles for RNA chaperones

| PRJNA543880 | ENA

Click-enabled analogues reveal pregnenolone interactomes in cancer and immune cells

Project description:Click-enabled analogues reveal pregnenolone interactomes in cancer and immune cells. TMT-6 experiment of tryptic, carbamidomethylated peptides of mouse CD8+ T-cells after protein pull-down on pregnenolone beads.

2021-04-26 | PXD025574 | Pride

Genetic determinants of venetoclax resistance

Project description:Genetic determinants of venetoclax resistance

| PRJNA528105 | ENA

Genetic determinants of antidepressant response

Project description:Genetic determinants of antidepressant response

| PRJNA988902 | ENA

Genetic determinants of antidepressant response

Project description:Genetic determinants of antidepressant response

| PRJNA988901 | ENA